Analyses of these datasets further reveals YB-1, HIF1A, CAIX and G3BP1 transcript levels to be increased in tumours with amplified AKT1 and/or increased AKT1 expression (Fig. 1E, F and Appendix Fig. S2E–H). The gene discussed is AKT1; the disease is neoplasm.